<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Tenofovir to prevent perinatal transmission of hepatitis B [Reply]</dc:title>
  <dc:creator>/Jourdain, Gonzague</dc:creator>
  <dc:creator>/Ngo-Giang-Huong, Nicole</dc:creator>
  <dc:creator>Harrison, L.</dc:creator>
  <dc:creator>iTAP Study Group</dc:creator>
  <dc:date>2018</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010073125</dc:identifier>
  <dc:identifier>fdi:010073125</dc:identifier>
  <dc:identifier>Jourdain Gonzague, Ngo-Giang-Huong Nicole, Harrison L., iTAP Study Group. Tenofovir to prevent perinatal transmission of hepatitis B [Reply]. 2018, 378 (24),  2350-2350</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>THAILANDE</dc:coverage>
</oai_dc:dc>